Identity on this record
Catalogue name: Cerebrolysin 60mg research preparation.
Composition: Mixture — no single sequence is assigned.
CAS number: Not applicable — mixture.
Catalog strength: 60 mg nominal fill.
Distinct from: Licensed injectable sold under the same trademark.
Those identifiers describe Cerebrolysin as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
Cerebrolysin 60mg is the 60 mg lyophilized unit, listed at AED 449 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for Cerebrolysin, not a delivered-cost quote.
Lots and certificates
Lot VL-CBL60-20261020 is the catalogue certificate for Cerebrolysin 60mg. Read it on Cerebrolysin 60mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
How the compound record describes the literature
Clinical papers that use the word Cerebrolysin are about a licensed porcine-brain preparation supplied as a solution by its manufacturer. This catalogue line is a 60 mg lyophilized research material under the same name. Those are not the same article of commerce. VaultLabs does not claim the licensed composition, does not invent a peptide list, and does not print a CAS number that would pretend the mixture is one substance.
Topics named on the Cerebrolysin record, as literature context rather than as outcomes VaultLabs claims: Nominal fill is 60 mg of lyophilized material.; No single CAS number. A mixture does not have one registry number.; Not a single-sequence peptide and not interchangeable with Semax or Pinealon.; Not the licensed porcine-brain injectable described in clinical papers..
That is context for identifying Cerebrolysin. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the Cerebrolysin monograph, so a reader can check them against that page:
Nominal fill is 60 mg of lyophilized material.
No single CAS number. A mixture does not have one registry number.
Not a single-sequence peptide and not interchangeable with Semax or Pinealon.
Not the licensed porcine-brain injectable described in clinical papers.
Identity for a received unit is the lot record.
Supplied for laboratory research. Not for human use.
Dispatch and the research-use boundary
VaultLabs dispatches Cerebrolysin from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the Cerebrolysin compound monograph. Handling of the sealed unit is the Cerebrolysin storage guide. Questions are collected on the Cerebrolysin FAQ. How it differs from neighbouring records is the Cerebrolysin comparison.